Infectious Diseases

289 Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.

288 Amoxicillin for 3 or 5 Days for Chest-Indrawing Pneumonia in Malawian Children.

287 A mobile app, the COVID Symptom Study, offers data on risk factors, early symptoms, clinical outcomes, and geographical hotspots.

286 Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States.

285 Remdesivir for the Treatment of Covid-19 — Preliminary Report.

284 Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.

283 Severe Covid-19.

282 Feedback between the epidemic process, the behavioral response to it, and nationwide containment policies can restrain COVID-19.

281 Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures.

280 Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.

279 Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.

278 Travel restrictions and the national emergency response delayed the growth and limited the size of the COVID-19 epidemic in China.

277 An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.

276 Mobile phone data show that the spread of COVID-19 in China was driven by travel and mitigated substantially by local control measures.

275 Prior to travel restrictions, most SARS-CoV-2 infections went undocumented and substantially contributed to global virus spread.

274 Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study.

273 A SARS-CoV-2 epidemiological model reveals the effects of travel restrictions and transmission reduction efforts on the spread of this novel virus.

272 Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.

271 Identification of tetranectin-targeting monoclonal antibodies to treat potentially lethal sepsis.

270 Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes.

Free Images for Presentation: sunipix SUNIPIX